ELABHealthcare · Biotechnology

ELAB Stock Forecast: PMGC Holdings, Inc. Price Predictions for 2026-2027

Last close, 24 Aug 2026

$6.52

−2.10% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 3 of 100 as at 22 Aug 2026 — in the weakest quartile.

Market cap

$5.4M

Ticker Nerd rank

3 / 100

Median analyst target

—

Analysts covering

—

Revenue$682K

Operating income−$3.3M

Net income−$5.0M

Free cash flow−$3.3M

Quarterly, 8 quarters to 31 Mar 2026 · latest quarter's figure shown

Total return, dividends reinvested

−25.3%

−27.6%

YTD

−98.2%

−99.7%

From 52W high

−99.7%

From 52W low

+16.4%

$2,167

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

ELAB stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores PMGC Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026

3 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Accruals

Revisions

Momentum

Value

Growth

Issuance

Quality

Volatility

Size (96): Smaller than most of the companies we track.

Volatility (0): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ELAB stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ELAB, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ELAB appears on the weeks it earns a place.

Performance

ELAB vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 24 Aug 2026, PMGC Holdings, Inc. returned −99.7% against +19.6% for the S&P 500, dividends included.

ELAB vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ELAB analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

PMGC Holdings, Inc. (ELAB) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 0.0×
Price / sales: 2.1×
Price / book: 0.2×
EV / EBITDA: −0.1×

Growth & margins

Revenue growth (YoY): 124.2%
Earnings growth (YoY): —
Gross margin: 33.8%
Operating margin: −290.0%
Net margin: 31.4%

Returns & dividend

Return on equity: −105.2%
Return on assets: −33.0%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

PMGC Holdings, Inc. (ELAB) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

PMGC Holdings, Inc. has a market value of $5.4M and an enterprise value of $667K.
Revenue in the twelve months to 31 Mar 2026: $1.3M. The latest quarter grew 124.2% year on year.
Net income over the same four quarters: −$11.1M, a −873.1% net margin.
Free cash flow in the twelve months to 31 Mar 2026: −$8.4M.
PMGC Holdings, Inc. spent $0.0 on share buybacks in the twelve months to 31 Mar 2026.
Shares outstanding: 1.9M.
Trailing P/E: 0.0×.
PMGC Holdings, Inc. employs 32 people — $40K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 23 Aug 2026

Data provided by Twelve Data

Peers

ELAB vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology

Company	Market cap	TKN rank
ELABPMGC Holdings, Inc.	$5.4M	3
PULMPulmatrix, Inc.	$5.5M	44
LABTLakewood-Amedex Biotherapeutics, Inc.	$5.3M	25
BRTXBioRestorative Therapies, Inc.	$5.5M	8
BCABBioAtla, Inc.	$5.3M	26
DRMADermata Therapeutics, Inc.	$5.7M	29
MLECMoolec Science SA	$5.1M	3

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own PMGC Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ELAB news & analysis

NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight

GlobeNewsWire · 21 Aug 2026neutral

NorthStrive Biosciences announced it has filed two U.S. patent applications targeting microgravity-induced muscle loss during long-duration spaceflight, as reported by GlobeNewsWire.

Why it matters — A watcher of ELAB would care because this patent filing could relate to the company's broader biosciences and space-health initiatives, potentially expanding its intellectual property and market focus.

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

GlobeNewsWire · 19 Aug 2026neutral

PMGC Holdings Inc. (NASDAQ: ELAB) announced it will effect a 1-for-10 reverse stock split of its issued, outstanding, and authorized common stock, effective at 12:00 am Eastern time on August 21, 2026.

Why it matters — ELAB watchers would care because the reverse stock split will consolidate the company's share count and raise the per-share price, altering the stock's market structure.

PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially

GlobeNewsWire · 14 Aug 2026positive

PMGC Holdings Inc. reported its Q2 2026 results and filed its Form 10-Q. Total assets reached $36.6 million, up 184% from year-end 2025 and 290% year-over-year, while quarterly revenue nearly doubled sequentially.

Why it matters — The report highlights significant asset growth and a strong sequential revenue increase for ELAB, marking notable expansion in the company's financial position.

PMGC Holdings Confirms Compliance with Nasdaq's New $5 Million Market Value of Listed Securities Requirement

GlobeNewsWire · 29 July 2026positive

PMGC Holdings announced it has met Nasdaq's $5 million market value of listed securities requirement, reporting 8,095,835 shares of common stock issued and outstanding as of July 29, 2026. The company is also working to correct third-party market data that understates its current share count and market capitalization.

Why it matters — For ELAB watchers, this confirms the company's continued compliance with Nasdaq listing requirements and addresses potential market-data inaccuracies that could affect perceived valuation.

PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.

GlobeNewsWire · 28 July 2026positive

PMGC Holdings Inc. announced a strategic investment in Precision Aerospace & Defense Group and a long-term aerospace and defense manufacturing agreement through its subsidiary A&B Aerospace Inc.

Why it matters — The investment and long-term agreement expand PMGC Holdings' footprint in the aerospace and defense manufacturing sector, a new strategic direction for the company.

FAQ

Frequently asked questions about ELAB stock

How does Ticker Nerd's model rank ELAB?

As at 22 Aug 2026, PMGC Holdings, Inc. ranks 3 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (96 of 100).

What is the ELAB stock forecast for 2030?

No analyst covering PMGC Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ELAB are extrapolating price history, which says nothing about the business.

How has ELAB stock performed over the past year?

PMGC Holdings, Inc. returned -99.7% over the 12 months to 24 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does PMGC Holdings, Inc. do?

PMGC Holdings Inc. is a diversified public holding company based in Newport Beach, California, founded in 2020.

What is the latest news on ELAB?

The most recent item we track (GlobeNewsWire, 21 Aug 2026): "NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight". NorthStrive Biosciences announced it has filed two U.S. patent applications targeting microgravity-induced muscle loss during long-duration spaceflight, as reported by GlobeNewsWire.

Company

About PMGC Holdings, Inc.

PMGC Holdings Inc. is a diversified public holding company based in Newport Beach, California, founded in 2020. The company focuses on acquiring and operating cash-flowing businesses primarily in the manufacturing sector, including IT packaging, CNC machining, mold manufacturing, and specialty metals operations serving aerospace, defense, and industrial markets. It maintains involvement in biopharmaceutical development through subsidiaries like Elevai Biosciences, which advances therapeutic products such as EL-22, an engineered probiotic designed to preserve muscle mass during weight loss treatments including GLP-1 receptor agonists. PMGC Holdings Inc. also engages in medical scientific research and operates investment firms. By divesting non-core assets like skincare operations, the company strengthens its balance sheet while pursuing strategic acquisitions to foster long-term value in high-demand industrial and healthcare innovation segments.

CEO Mr. Graydon Bensler C.F.A. · 32 employees · United States · https://pmgcholdings.com